Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Ligand for the SH3 Domain of P13
Andreotti, Amy H.
Harvard University, Boston, MA, United States
Search 33 grants from Amy Andreotti
Search grants from Harvard University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Impact of Corticotropin Releasing Factor on Sleep Regulation
Linking oncogenic signaling to tumor metabolism
Syndecan-2 and Clinical Progression of Idiopathic Pulmonary Fibrosis
Emotions Matter:Classroom-based Integrated Intervention
Control of Ig Gene Expression in Ig Transgenic Mice
Recently added grants:
An Integrative Approach to Identify Vulnerabilities in Pediatric Cancer DSRCT
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Administrative Core
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM016960-01
Application #
2171769
Study Section
Biomedical Sciences Study Section (BIOM)
Project Start
1995-03-29
Project End
Budget Start
1994-10-03
Budget End
1995-10-02
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Harvard University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1995
F32 GM
Novel Ligand for the SH3 Domain of P13
Andreotti, Amy H. / Harvard University
NIH 1994
F32 GM
Novel Ligand for the SH3 Domain of P13
Andreotti, Amy H. / Harvard University
Comments
Be the first to comment on Amy Andreotti's grant